Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Chemistry|February 11, 2015
Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agentsMariano Stornaiuolo, Giuseppe La Regina, Sara Passacantilli, et al.
Scientific Reports|April 24, 2014
Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastomaSimona Daniele, Sabrina Taliani, Eleonora Da Pozzo, et al.
European Journal of Medicinal Chemistry|April 5, 2025
2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targetingMaria Luisa Di Paolo, Silvia Salerno, Giulia Nordio, et al.
Journal of Medicinal Chemistry|October 12, 2007
5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonistsFederico Da Settimo, Giampaolo Primofiore, Sabrina Taliani, et al.
Journal of Medicinal Chemistry|January 23, 2014
Structure-based optimization of tyrosine kinase inhibitor CLM3. Design, synthesis, functional evaluation, and molecular modeling studiesStefania Sartini, Vito Coviello, Agostino Bruno, et al.
European Journal of Medicinal Chemistry|November 18, 2011
Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimizationValeria La Pietra, Luciana Marinelli, Sandro Cosconati, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Enriching the Arsenal of Pharmacological Tools against MICAL2Ivana Barravecchia, Elisabetta Barresi, Camilla Russo, et al.
Journal of Medicinal Chemistry|August 31, 2013
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitorsSabrina Taliani, Isabella Pugliesi, Elisabetta Barresi, et al.
Pageof 14